The risk of lymph node metastasis in patients with T2 colon cancer

It is often safe to treat pT1 tumours with local resection due to the low risk of lymph node metastasis. The risk of lymph node metastasis in pT2 colon cancer is less well investigated. The recommendation for patients diagnosed with T2 colon cancer is a segmental resection including regional lymph nodes. The aim of this work was to determine the risk of lymph node metastasis in pT2 colon cancer and identify the possible associated clinical and pathological risk factors for lymph node metastasis.

[1]  M. Page,et al.  PRISMA2020: An R package and Shiny app for producing PRISMA 2020‐compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis , 2021, medRxiv.

[2]  M. Zheng,et al.  Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial. , 2021, The Lancet. Oncology.

[3]  M. Sorribas,et al.  Combined endoscopic-laparoscopic surgery (CELS) can avoid segmental colectomy in endoscopically unremovable colonic polyps: a cohort study over 10 years , 2021, Surgical Endoscopy.

[4]  Herng‐Sheng Lee,et al.  Using the Fat-Clearing Technique to Improve Lymph Node Retrieval in Colorectal Cancer , 2020, International journal of surgical pathology.

[5]  J. Kleif,et al.  Accuracy of preoperative staging with multidetector computed tomography in colon cancer , 2020, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[6]  R. Labianca,et al.  Localised Colon Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  S. Laurberg,et al.  Long-term bowel dysfunction after right-sided hemicolectomy for cancer , 2020, Acta oncologica.

[8]  J. Huh,et al.  Risk factors for lymph node metastasis in early colon cancer , 2020, International Journal of Colorectal Disease.

[9]  P. Krarup,et al.  Lymphovascular Infiltration, Not Depth of Invasion, is the Critical Risk Factor of Metastases in Early Colorectal Cancer , 2020, Annals of surgery.

[10]  K. McGlynn,et al.  Age and Lymph Node Positivity in Patients With Colon and Rectal Cancer in the US Military Health System , 2019, Diseases of the colon and rectum.

[11]  Jiwei Yu,et al.  Population-based analysis on predictors for lymph node metastasis in T1 colon cancer , 2019, Surgical Endoscopy.

[12]  Hao Zhang,et al.  Young age increases the risk for lymph node metastasis in patients with early Colon Cancer , 2019, BMC Cancer.

[13]  I. Gögenur,et al.  Combined endoscopic laparoscopic surgical treatment of advanced adenomas and early colon cancer. , 2019, Danish medical journal.

[14]  M. Roberts,et al.  Impact of Age on Risk of Lymph Node Positivity in Patients with Colon Cancer , 2019, Journal of Cancer.

[15]  S. Njor,et al.  Effectiveness of Colorectal Cancer Screening in Detecting Earlier-Stage Disease-A Nationwide Cohort Study in Denmark. , 2018, Gastroenterology.

[16]  O. Abdel-Rahman.  Revisiting Dukes’ paradigm; some node positive colon cancer patients have better prognosis than some node negative patients , 2018, Clinical and Translational Oncology.

[17]  Tomohiro Yamaguchi,et al.  The distribution of lymph node metastases and their size in colon cancer , 2017, Langenbeck's Archives of Surgery.

[18]  N. Nguyen,et al.  Lymph Node Positivity in Appendiceal Adenocarcinoma: Should Size Matter? , 2017, Journal of the American College of Surgeons.

[19]  H. Weir,et al.  The TNM classification of malignant tumours-towards common understanding and reasonable expectations. , 2017, The Lancet. Oncology.

[20]  J. Schofield,et al.  Assessment of lymph node involvement in colorectal cancer. , 2016, World journal of gastrointestinal surgery.

[21]  M. Nojima,et al.  Factors associated with risk for colorectal cancer recurrence after endoscopic resection of T1 tumors. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[22]  Cord Langner,et al.  Lymph node staging in colorectal cancer: old controversies and recent advances. , 2013, World journal of gastroenterology.

[23]  L. Påhlman,et al.  Lymph nodes, tumor deposits, and TNM: are we getting better? , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  H. Ueno,et al.  Risk Factors of Nodal Involvement in T2 Colorectal Cancer , 2010, Diseases of the colon and rectum.

[25]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[26]  T. Akasu,et al.  Optimum Lymph Node Dissection in Clinical T1 and Clinical T2 Colorectal Cancer , 2009, Diseases of the colon and rectum.

[27]  S. Laurberg,et al.  Increased lymph node harvest from colorectal cancer resections using GEWF solution: a randomised study , 2008, Journal of Clinical Pathology.

[28]  A. Kneebone,et al.  Direct Tumor Invasion in Colon Cancer: Correlation with Tumor Spread and Survival , 2008, Diseases of the colon and rectum.

[29]  Shung-Haur Yang,et al.  Metastatic potential in T1 and T2 colorectal cancer. , 2005, Hepato-gastroenterology.

[30]  L. Sobin,et al.  TNM classification , 2001 .

[31]  J. Jass,et al.  Clinicopathological staging for colorectal cancer: An International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT) , 1991, Journal of Gastroenterology and Hepatology.

[32]  V. Lemmens,et al.  Large variation between hospitals and pathology laboratories in lymph node evaluation in colon cancer and its impact on survival, a nationwide population-based study in the Netherlands. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[33]  D. Driman,et al.  GEWF solution. , 2001, Archives of pathology & laboratory medicine.

[34]  Maurice B Loughreya,et al.  Dataset for pathology reporting of colorectal cancer: recommendations from the International Collaboration on Cancer Reporting (ICCR) , 2022 .